Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar;17(3):577-82.
doi: 10.1110/ps.073271408. Epub 2008 Jan 24.

Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site

Affiliations

Structure of a small-molecule inhibitor complexed with GlmU from Haemophilus influenzae reveals an allosteric binding site

Igor Mochalkin et al. Protein Sci. 2008 Mar.

Abstract

N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU) is an essential enzyme in aminosugars metabolism and an attractive target for antibiotic drug discovery. GlmU catalyzes the formation of uridine-diphospho-N-acetylglucosamine (UDP-GlcNAc), an important precursor in the peptidoglycan and lipopolisaccharide biosynthesis in both Gram-negative and Gram-positive bacteria. Here we disclose a 1.9 A resolution crystal structure of a synthetic small-molecule inhibitor of GlmU from Haemophilus influenzae (hiGlmU). The compound was identified through a high-throughput screening (HTS) configured to detect inhibitors that target the uridyltransferase active site of hiGlmU. The original HTS hit exhibited a modest micromolar potency (IC(50) approximately 18 microM in a racemic mixture) against hiGlmU and no activity against Staphylococcus aureus GlmU (saGlmU). The determined crystal structure indicated that the inhibitor occupies an allosteric site adjacent to the GlcNAc-1-P substrate-binding region. Analysis of the mechanistic model of the uridyltransferase reaction suggests that the binding of this allosteric inhibitor prevents structural rearrangements that are required for the enzymatic reaction, thus providing a basis for structure-guided design of a new class of mechanism-based inhibitors of GlmU.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
Figure 1.
Figure 1.
hiGlmU in complex with allosteric inhibitor 1. (A) View of the electrostatic surface potential of hiGlmU at the uridyltransferase active site and the allosteric region. Positive electrostatic potential is colored blue. Negative potential is colored red. Inhibitor 1 bound at the allosteric site is colored in the following atom colors: carbon, green; nitrogen, blue; oxygen, red; chlorine, orange. UDP-GlcNAc (PDB code 2v0i) shown at the substrate-binding site is colored in the following atom colors: carbon, yellow; nitrogen, blue; oxygen, red. (B) View of an OMIT electron density map contoured at 3σ level. (C) A schematic representation of inhibitor 1/hiGlmU interactions drawn using the MOE program (Chemical Computing Group, CCG). Hydrophobic residues are colored with a green interior; polar residues are colored in light purple. Basic residues are further annotated by a blue interior ring, and acidic residues with a red ring. The hydrogen-bonding interaction between the E224 side chain of hiGlmU and inhibitor 1 is drawn with a green arrowhead. (D) View of the superimposed hiGlmU coordinates from the complex with inhibitor 1 (colored in magenta), the product UDP-GlcNAc (colored in blue; PDB code 2v0i) and the apo form (colored in gold; PDB code 2v0h). In the UDP-GlcNAc and inhibitor 1 bound structures, the active site undergoes a substantial structural rearrangement, including the movement of residues N146, K156, and A160 by 5.5 Å, 5.9 Å, and 6.9 Å, respectively (distance measures between Cα pairs). Binding of inhibitor 1 prevents the structural rearrangement from open (apo-like) to closed (product-bound) conformations.
Scheme 2.
Scheme 2.
Scheme 3.
Scheme 3.

Similar articles

Cited by

References

    1. Anderson, M.S., Raetz, C.R.H. Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acetyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. J. Biol. Chem. 1987;262:5159–5169. - PubMed
    1. Brown, K., Pompeo, F., Dixon, S., Mengin-Lecreulx, D., Cambillau, C., Bourne, Y. Crystal structure of the bifunctional N-acetylglucosamine-1-phosphate uridyltransferase from Escherichia coli: A paradigm for the related pyrophosphorylase superfamily. EMBO J. 1999;18:4096–4107. - PMC - PubMed
    1. Brünger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M., Pannu, N.S., et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. 1998;D54:905–921. - PubMed
    1. Collaborative Computational Project, Number 4. The CCP4 Suite: Programs for protein crystallography. Acta Crystallogr. 1994;D50:760–763. - PubMed
    1. Gehring, A.M., Lees, W.J., Mindiola, D.J., Walsh, C.T., Brown, E.D. Acetyltransfer precedes uridyltransfer in the formation of UDP-N-acetylglucosamine in separable active sites of the bifunctional glmu protein of Escherichia coli . Biochemistry. 1996;35:579–585. - PubMed

Publication types

Substances

Associated data

LinkOut - more resources